Back to mobile site

Faeth Therapeutics (FTH) Reiterated at Overweight by Cantor Fitzgerald After Investor Day

October 7, 2026 6:50 AM EDT Send to a Friend
Cantor Fitzgerald analyst Li Watsek reiterated an Overweight rating on Faeth Therapeutics (NASDAQ: FTH).The analyst commented, "Faeth’s inaugural investor/analyst day ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login